US demand for drug delivery systems is projected to expand more than ten percent annually to $132 billion in 2012. Growth opportunities for drug delivery systems extend into all therapeutic classes of pharmaceuticals and encompass a wide range of compounds and formulations. Central nervous system, respiratory and hormone and related agents will remain the top three applications based on the special formulating needs of medicines for conditions such as arthritis, multiple sclerosis, asthma, allergies and cancer. However, favorable growth opportunities will emerge for drug delivery systems in most other therapeutic classes due to safety and efficacy shortcomings in many conventional medicines.
Parenteral types to exhibit best growth opportunities
Oral drug delivery systems will remain the largest method used for drug delivery. Orally disintegrating tablets and transmucosal drugs will generate strong growth opportunities in the delivery of pain control and other critical care medication. Ease of administration advantages will promote the widening use of chewable tablet dosages for nutritional, respiratory and central nervous system agents, especially pediatric preparations. Better solubility and pharmacokinetic actions will lead to rapid growth both in the number and sales of oral nanoparticle drugs. Among pharmaceutical dosage formulations, parenteral preparations will provide the strongest growth opportunities for drug delivery systems. Precise targeting advantages in the treatment of cancer and other debilitating diseases will broaden demand for therapeutic monoclonal antibodies. Extended circulation and reduced toxicity benefits will expand the range of indications served by polymer- and liposome-encapsulated drugs, especially in the areas of cancer, neurological and anti-infective therapies. Ease of administration andinfection prevention advantages will boost the market for parenteral drugs and solutions sold in prefilled syringes and premixed IV systems. An increasing incidence of chronic respiratory conditions, coupled with the need for safer and more effective therapies, will boost growth prospects for inhalation drug delivery systems. Based on widespread use in asthma therapy, dry powder inhaler formulations will continue to record the largest share of sales. However, metered dose drugs will see slightly faster gains in demand due to ongoing improvements in particle size and propellent safety. Lastly, transdermal patches will continue to broaden pharmaceutical applications as advances in administration modalities and design lead to new uses in pain control and cardiovascular medication.
Study coverage
It presents historical demand data (1997, 2002, 2007) plus forecasts for 2012 and 2017 by type and application. The study also considers US market environment factors, evaluates company market share and profiles 43 industry competitors.
Table of Content
Executive Summary
1 Executive Summary
Market ENVIRONMENT
General
Macroeconomic Trends
Deographic Patterns
Health Care Trends
Health Insurance
Medical Conditions
Acute Conditions
Chronic Conditions
National Health Expenditures
Medical Providers
Patient Activity
Pharmaceutical Market Overview
Regulation
Research & Development
Demand Patterns & Forecasts
Therapeutic Classes
Generic Competition
Ethical Pharmaceuticals
Over-the-Counter Pharmaceuticals
1 Macroeconomic Indicators
2 Population by Age Group
3 Acute Conditions by Type
4 Chronic Conditions by Type
5 National Health Expenditures by Type
6 Selected Medical Providers
7 Selected Patient Activity
8 Pharmaceutical Demand
by Therapeutic Class
9 Pharmaceutical Demand
by Commercial Status
10 Pharmaceutical Demand
by Dosage Formulation
11 Pharmaceutical Demand
by Regulatory Classification
DRUG Delivery Materials
General
Sterile & Purified Water
Synthetic Polymers
Cellulose Derivatives
Minerals
Other Materials
Starch Compounds
Natural Gums
Sugars & Polyols
All Other Materials
1 Drug Delivery Material Demand by Type
Cht Drug Delivery System Material
Demand by Type
2 Sterile & Purified Water Demand
in Drug Delivery Systems
3 Synthetic Polymer Demand
in Drug Delivery Systems
4 Cellulose Derivative Demand
in Drug Delivery Systems
5 Mineral Demand in Drug Delivery Systems
6 Other Material Demand
in Drug Delivery Systems
DRUG Delivery Systems OVERVIEW
General
Types of Drug Delivery Systems
Technologies
Historical Demand Patterns
US Trade
International Markets
1 Drug Delivery System Demand by Type
Cht Drug Delivery System Demand by Type, 2007
2 Drug Delivery System Demand
Patterns, 1997-2007
3 US Trade in Drug Delivery Systems
4 World Drug Delivery System Demand
Oral DRUG Delivery Systems
General
Sustained-Release Formulations
Tablet Formulations
Capsule Formulations
Other Formulations
Delayed-Release Formulations
Capsule Formulations
Tablet Formulations
Chewable Tablets
Orally Disintegrating Tablets
Nanoparticle Formulations
Transmucosal Formulations
1 Oral Drug Delivery System Demand by Type
Cht Oral Drug Delivery System
Demand by Type, 2007
2 Sustained-Release Pharmaceutical Demand
by Therapeutic Class & Formulation
3 Delayed-Release Pharmaceutical Demand
by Therapeutic Class & Formulation
4 Chewable Tablet Demand
by Therapeutic Class
5 Orally Disintegrating Tablet Demand
by Therapeutic Class
6 Nanoparticle-
Demand by Therapeutic Class
7 Oral Transmucosal Pharmaceutical Demand
by Therapeutic Class
Potential DRUG Delivery Systems
General
Therapeutic Monoclonal Antibodies
Anti-Cancer Agents
Central Nervous System Agents
Other
Prefilled Syringes
Injectors
Cartridges & Pens
Encapsulated Formulations
Polymer-Protected
Liposomes
Premixed IV Solutions
Bag/Vial Infusion Systems
Mini-Bags
Other
1 Parenteral Drug Delivery System
Demand by Type
Cht Parenteral Drug Delivery System
Demand by Type, 2007
2 Therapeutic Monoclonal Antibody
Demand by Therapeutic Class
3 Prefilled Syringe Demand
by Type & Therapeutic Class
4 Encapsulated Parenteral Pharmaceutical
Demand by Type & Therapeutic Class
5 Premixed IV Solution Demand
by Type & Therapeutic Class
Inhalation, Implantable & TRaNSDERMaL DRUG
Delivery Systems
General
Inhalation Drug Delivery Systems
Dry Powder Formulations
Metered Dose Spray Formulations
Aerosol Formulations
Implantable Drug Delivery Systems
Drug-Eluting Stents
Drug Inserts
Brachytherapy Seeds
Transdermal Drug Delivery Systems
Central Nervous System Agents
Hormones & Related Agents
Cardiovascular Agents
Other
1 Inhalation, Implantable & Transdermal Drug
Delivery System Demand by Type
2 Inhalation Drug Delivery System Demand
by Type & Therapeutic Class
Cht Inhalation Drug Delivery System
Demand by Type, 2007
For more information, please visit:
http://www.bharatbook.com/
